Lead account planning, management, and engagement activities at assigned payers to achieve rapid and clinically appropriate access for patients. This includes establishing and further developing relationships with decision makers at key customers
Support development of apitegromab’s value proposition and other supporting materials, including any account-specific needs
Maintain a strong understanding of apitegromab Commercial objectives and how to help achieve these goals through assigned accounts
Work across teams to ensure patient access objectives are met, including pull-through
Ensure all programs are aligned to Scholar Rock values and remain compliant with regulations
Lead presence with target accounts at access-related meetings, events and congresses (e.g., AMCP, PCMA, Asembia, Medicaid meetings, etc)
Collaborate with Insights and Analytics and Commercial Operations to derive account-level insights and actions; communicate access and coverage performance regularly to internal stakeholders
Proactively identify and execute against opportunities to improve patient access to care, within and outside of Value & Access
Be a content expert on relevant industry trends, market dynamics, policy and legislation and define implications and actions for Scholar Rock
Be a collaborative, strategic market access presence throughout the Scholar Rock organization
Requirements
Bachelors degree
At least 6 years’ experience in US Market Access with a deep understanding of evolving access, coverage, and reimbursement landscape
Experience and relationships with national and key regional Commercial, Medicaid, and other Government payers. Experience with VA/DoD/Tricare and Humana are strongly encouraged
Proven track record of achieving rapid, broad, and clinically appropriate coverage for medical benefit and/or rare disease products at launch
Comprehensive understanding of payer decision making bodies and cycles, processes/procedures, and data and reporting
Experience negotiating agreements with large healthcare systems preferred
Pre-launch experience at a small, start-up biotechnology company preferred